[#item_full_content]Citi’s net income rose 15% to $3.8 billion from a year earlier, while revenues were up…
Author: Mb
Jamie Dimon says auto company bankruptcies reveal ‘early signs’ of excess in corporate lending
[#item_full_content]The bankruptcies have sparked concern about the risks involved when banks like JPMorgan, Jefferies and Fifth…
Citi reports a rise in earnings with every business posting record third-quarter revenue
[#item_full_content]Citi’s net income rose 15% to $3.8 billion from a year earlier, while revenues were up…
JPMorgan Chase tops estimates as trading revenue hits a record of nearly $9 billion
[#item_full_content]CEO Jamie Dimon said that while each of his major business lines performed well against a…
Goldman Sachs beats estimates on better-than-expected investment banking, bond trading
[#item_full_content]Goldman Sachs gets the majority of its revenue from Wall Street activities including trading and investment…
Goldman Sachs beats estimates on better-than-expected investment banking, bond trading
[#item_full_content]Goldman Sachs gets the majority of its revenue from Wall Street activities including trading and investment…
JPMorgan Chase tops estimates as trading revenue hits a record of nearly $9 billion
[#item_full_content]CEO Jamie Dimon said that while each of his major business lines performed well against a…
Goldman Sachs earnings are out – Here are the numbers
[#item_full_content]Goldman Sachs gets the majority of its revenue from Wall Street activities including trading and investment…
JPMorgan Chase tops estimates as trading revenue hits a record of nearly $9 billion
[#item_full_content]JPMorgan will give investors a view into how U.S. consumers and corporations fared in the third…
Circle Pharma Announces Upcoming Poster Presentation Highlighting the Anti-tumor Potential of Cyclin D1 RxL Inhibition at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
[#item_full_content]SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Circle Pharma, Inc., a clinical-stage biopharmaceutical company pioneering next-generation targeted macrocycle therapeutics…